PXT-3003

· Pharnext S.C.A

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PXT-3003, covering 2017-02-16 to 2017-02-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A [Phase 2]